Annagur, Bilge BurcakAkbaba, Nursel2020-03-262020-03-2620162146-14732146-2380https://dx.doi.org/10.5455/jmood.20160504020923https://hdl.handle.net/20.500.12395/33261Neuroleptic malignant syndrome (NMS) is a rare, life-threatening idiosyncratic reaction secondary to antipsychotic medication. Hyponatremia frequently develops in elderly patients and also psychiatric patients and may associate with neuroleptic malignant syndrome. This case report presents a male patient developing NMS secondary to antipsychotic dose escalation on the basis of hyponatremia.en10.5455/jmood.20160504020923info:eu-repo/semantics/closedAccessantidepressant side effecthyponatremianeuroleptic malignant syndromeArticle627173#YOKWOS:000387949200004N/A